Table: Fuji Pharmaceutical - 6-MTH group results
May 6 (Reuters)-
Fuji Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Mar 31, 2022 Mar 31, 2021 Sep 30, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 17.73 17.28 35.97
(+2.6 pct) (+2.2 pct) (+10.2 pct)
Operating 2.71 2.69 3.49
(+1.0 pct) (+54.8 pct) (+4.2 pct)
Recurring 2.87 2.74 3.54
(+4.7 pct) (+70.0 pct) (+8.9 pct)
Net 1.83 2.02 2.56
(-9.3 pct) (+550.5 pct) (+5.3 pct)
EPS 75.50 yen 68.63 yen 105.49 yen
Ann Div 29.00 yen 32.00 yen
-Q2 div 15.00 yen 14.00 yen
-Q4 div 15.00 yen 17.00 yen
NOTE - Fuji Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T